KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Operating Margin (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -75.00
Dec 31, 2025 1,527.00
Sep 30, 2025 -1,966.00
Jun 30, 2025 375.00
Mar 31, 2025 3,784.00
Dec 31, 2024 -3,636.00
Sep 30, 2024 -115.00
Jun 30, 2024 492.00
Mar 31, 2024 39.00
Dec 31, 2023 596.00
Sep 30, 2023 -1,617.00
Jun 30, 2023 991.00
Mar 31, 2023 -1,374.00
Dec 31, 2022 531.00
Sep 30, 2022 848.00
Jun 30, 2022 -1,225.00
Mar 31, 2022 76.00
Dec 31, 2021 406.00
Sep 30, 2021 -179.00
Jun 30, 2021 28.00
Mar 31, 2021 446.00
Dec 31, 2020 185.00
Sep 30, 2020 1,802.00
Jun 30, 2020 -3,459.00
Mar 31, 2020 -365.00
Dec 31, 2019 1,459.00
Sep 30, 2019 -1,032.00
Jun 30, 2019 274.00
Mar 31, 2019 6,784.00
Dec 31, 2018 -6,775.00
Sep 30, 2018 499.00
Jun 30, 2018 -322.00
Mar 31, 2018 1,356.00
Dec 31, 2017 -1,549.00
Sep 30, 2017 18.00
Jun 30, 2017 152.00
Mar 31, 2017 277.00
Dec 31, 2016 -266.00
Sep 30, 2016 3,810.00
Jun 30, 2016 -3,963.00
Mar 31, 2016 522.00
Dec 31, 2015 130.00
Sep 30, 2015 -28,324.00
Jun 30, 2015 28,148.00
Mar 31, 2015 4,108.00
Dec 31, 2014 -2,674.00
Sep 30, 2014 -1,163.00
Jun 30, 2014 115.00
Mar 31, 2014 -43.00
Dec 31, 2013 60.00
Sep 30, 2013 -153.00
Jun 30, 2013 82.00
Mar 31, 2013 -483.00
Dec 31, 2012 -42.00
Sep 30, 2012 375.00
Jun 30, 2012 821.00